[go: up one dir, main page]

DK0970701T3 - Pellets afledt fra keratinocytter til anvendelse som sårhelingsstoffer - Google Patents

Pellets afledt fra keratinocytter til anvendelse som sårhelingsstoffer

Info

Publication number
DK0970701T3
DK0970701T3 DK99114054T DK99114054T DK0970701T3 DK 0970701 T3 DK0970701 T3 DK 0970701T3 DK 99114054 T DK99114054 T DK 99114054T DK 99114054 T DK99114054 T DK 99114054T DK 0970701 T3 DK0970701 T3 DK 0970701T3
Authority
DK
Denmark
Prior art keywords
keratinocytes
wound healing
healing agents
pellet
pellets derived
Prior art date
Application number
DK99114054T
Other languages
English (en)
Inventor
Bossuyt Hans Van
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Application granted granted Critical
Publication of DK0970701T3 publication Critical patent/DK0970701T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0629—Keratinocytes; Whole skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99114054T 1991-11-20 1992-11-19 Pellets afledt fra keratinocytter til anvendelse som sårhelingsstoffer DK0970701T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91403137 1991-11-20
EP92923745A EP0615545B1 (en) 1991-11-20 1992-11-19 Lysates derived from keratinocytes for use as wound healing substances

Publications (1)

Publication Number Publication Date
DK0970701T3 true DK0970701T3 (da) 2006-03-06

Family

ID=8208640

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99114054T DK0970701T3 (da) 1991-11-20 1992-11-19 Pellets afledt fra keratinocytter til anvendelse som sårhelingsstoffer
DK92923745T DK0615545T3 (da) 1991-11-20 1992-11-19 Lysater hidrørende fra keratinocytter til brug som sårhelingsmidler

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK92923745T DK0615545T3 (da) 1991-11-20 1992-11-19 Lysater hidrørende fra keratinocytter til brug som sårhelingsmidler

Country Status (10)

Country Link
US (2) US6126935A (da)
EP (2) EP0615545B1 (da)
JP (1) JP3311351B2 (da)
AT (2) ATE193057T1 (da)
CA (1) CA2123683C (da)
DE (2) DE69233558T2 (da)
DK (2) DK0970701T3 (da)
ES (2) ES2149779T3 (da)
GR (1) GR3034195T3 (da)
WO (1) WO1993010217A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3377354B2 (ja) * 1995-12-25 2003-02-17 株式会社メニコン 人工皮膚
US5935850A (en) * 1996-09-30 1999-08-10 The Research Foundation Of State University Of New York Model for cell migration and use thereof
US6274163B1 (en) * 1998-04-08 2001-08-14 Keraplast Technologies, Ltd. Keratinous protein material for wound healing applications and method
EP1053309B1 (en) * 1998-02-13 2006-11-22 The Wistar Institute Compositions and methods for wound healing
WO2000073418A2 (en) * 1999-05-28 2000-12-07 Pacgen Technologies Llc A method of using autologous fibroblasts to promote healing of wounds and fistulas
US6270791B1 (en) 1999-06-11 2001-08-07 Keraplast Technologies, Ltd. Soluble keratin peptide
GB2369572A (en) 2000-11-29 2002-06-05 Raft Trustees Ltd Wound treatment composition comprising insulin
AUPR298901A0 (en) 2001-02-07 2001-03-08 McComb Foundation, Inc., The Cell suspension preparation technique and device
US6623733B1 (en) * 2001-06-27 2003-09-23 Advanced Cardiovascular Systems, Inc. Methods for treatment of vascular disease and device for preparation of an autologous composition for treating vascular disease
DE10151296A1 (de) 2001-10-17 2003-04-30 Boehringer Ingelheim Pharma Keratinozyten verwendbar als biologisch aktive Substanz bei der Behandlung von Wunden
US8394371B2 (en) * 2002-02-11 2013-03-12 Neocutis Sa Compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
CN100369630C (zh) * 2002-12-03 2008-02-20 细胞移种有限公司 细胞裂解物的药用组合物及其生产和使用方法
GB0304918D0 (en) * 2003-03-05 2003-04-09 Celltran Ltd Cell culture
WO2005071063A1 (en) * 2004-01-27 2005-08-04 The Hospital For Sick Children Methods of making and using skin-derived stem cells
US20060058238A1 (en) * 2004-09-15 2006-03-16 Lee Laurent-Applegate Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
US20070004036A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for keratinocyte culture
US20070128685A1 (en) * 2005-07-01 2007-06-07 Rodolfo Faudoa Methods and compositions for cell culture
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
GB2444232A (en) * 2006-11-30 2008-06-04 Ethicon Inc Wound dressing compositions comprising cell lysates
US20100143477A1 (en) * 2007-07-27 2010-06-10 Immuneregen Biosciences, Inc. Methods and Compositions for Stimulating the Proliferation or Differentiation of Stem Cells with Substance Por an Analog Thereof
WO2009051622A2 (en) * 2007-10-12 2009-04-23 Immuneregen Biosciences, Inc. Methods for stimulating fibroblast proliferation using substance p analogs
US8580314B2 (en) 2008-11-04 2013-11-12 Stratatech Corporation Dried and irradiated skin equivalents for ready use
US20130230494A1 (en) * 2010-05-25 2013-09-05 The Research Foundation Of State University Of New York Cellular Preparations For Wound Management
JP6216318B2 (ja) * 2011-09-30 2017-10-18 株式会社アモーレパシフィックＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ 角化細胞に適応したメラニン形成細胞又はその前駆細胞
KR101410065B1 (ko) * 2011-12-09 2014-06-27 테고사이언스 (주) 세포의 유용물질을 상온에서 안정하게 보존하는 방법
AU2013205148B2 (en) 2013-03-14 2014-10-30 AVITA Medical Americas, LLC Systems and methods for tissue processing and preparation of cell suspension therefrom
EP3132809A1 (en) 2015-08-21 2017-02-22 Bioskinco GmbH Composition and products comprising senescent cells for use in tissue regeneration
EP4069824A1 (en) * 2019-12-02 2022-10-12 Avant Meats Company Limited Methods of meat production by in vitro cell cultivation
US11306342B2 (en) 2019-12-02 2022-04-19 Avant Meats Company Limited Cell hydrolysate composition from cultivated cells and applications thereof
US12037625B2 (en) * 2021-04-09 2024-07-16 Avant Meats Company Limited Cell hydrolysate composition from cultivated cells and applications thereof
US12281298B2 (en) 2022-12-27 2025-04-22 AVITA Medical Americas, LLC System for automated preparation of a regenerative epidermal suspension and related methods of use

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016036A (en) * 1975-11-14 1977-04-05 Massachusetts Institute Of Technology Process for serially culturing keratinocytes
LU73893A1 (da) * 1975-11-28 1977-06-09
US4299819A (en) * 1979-01-02 1981-11-10 Sloan-Kettering Institute For Cancer Research Process for treating burn victims
US4254226A (en) * 1979-09-13 1981-03-03 Sloan Kettering Institute For Cancer Research Process for growing human epidermal cells in tissue culture
US4304866A (en) * 1979-11-14 1981-12-08 Massachusetts Institute Of Technology Transplantable sheets of living keratinous tissue
US4443546A (en) * 1980-07-07 1984-04-17 The Beth Israel Hospital Association Process and composition for propagating mammalian cells
US5000963A (en) * 1983-06-14 1991-03-19 Hefton John M Method of treating the skin using human epidermal sheets
US4673649A (en) * 1983-07-15 1987-06-16 University Patents, Inc. Process and defined medium for growth of human epidermal keratinocyte cells
US4940666A (en) * 1983-07-15 1990-07-10 University Patents, Inc. Process and defined medium for growth of human epidermal keratinocyte cells
DE3688168T2 (de) * 1985-08-14 1993-10-28 Memorial Hospital Cancer Epidermiszellenextrakte und Verfahren zur Verbesserung der Wundheilung und zur Regenerierung der Epidermis.
US5273877A (en) * 1985-12-24 1993-12-28 Massachusetts Institute Of Technology Non-histological cell type determination
JPH0687301B2 (ja) * 1986-01-24 1994-11-02 富士写真フイルム株式会社 磁気記録媒体の製造方法
US5460939A (en) * 1986-04-18 1995-10-24 Advanced Tissue Sciences, Inc. Temporary living skin replacement
US5273900A (en) * 1987-04-28 1993-12-28 The Regents Of The University Of California Method and apparatus for preparing composite skin replacement
US4888291A (en) * 1987-06-19 1989-12-19 President And Fellows Of Harvard College Human epithelium originating from cell cultures
IT1207525B (it) * 1987-06-23 1989-05-25 Ist Naz Ric Sul Cancro Metodo per la preservazione difogli trapiantabili di epitelio coltivato in vitro vitale.
JPH01256330A (ja) * 1988-04-04 1989-10-12 Zenkoku Nogyo Kyodo Kumiai Rengokai ハイブリッド稲の種子生産方法
CA2000181A1 (en) * 1988-10-14 1990-04-14 Chung-Faye Chao Process for producing cultured epidermal sheet, product and method of use
US4996154A (en) * 1989-05-04 1991-02-26 Millipore Corporation Method for growing cellular tissue
US5262298A (en) * 1989-05-12 1993-11-16 The State Of Oregon Acting By And Through The State Board Of Education On Behalf Of The Oregon Health Sciences University Method to assess the ability of a substance to inhibit or stimulate keratinocyte autocrine factor production
CA2018228C (en) * 1989-06-05 1996-02-27 Nancy L. Parenteau Cell culture systems and media
US5130142A (en) * 1990-10-31 1992-07-14 The Practer & Gamble Company Hair growth regulating composition comprising epithelium cell supernatant-derived growth factor

Also Published As

Publication number Publication date
HK1027022A1 (en) 2001-01-05
ATE193057T1 (de) 2000-06-15
JP3311351B2 (ja) 2002-08-05
EP0970701A3 (en) 2001-12-05
GR3034195T3 (en) 2000-11-30
DE69231063D1 (de) 2000-06-21
EP0615545B1 (en) 2000-05-17
US5866167A (en) 1999-02-02
DK0615545T3 (da) 2000-10-30
DE69233558D1 (de) 2005-12-01
ES2252893T3 (es) 2006-05-16
EP0615545A1 (en) 1994-09-21
WO1993010217A1 (en) 1993-05-27
EP0970701B1 (en) 2005-10-26
ES2149779T3 (es) 2000-11-16
JPH07501214A (ja) 1995-02-09
ATE307599T1 (de) 2005-11-15
DE69233558T2 (de) 2006-07-27
CA2123683A1 (en) 1993-05-27
EP0970701A2 (en) 2000-01-12
CA2123683C (en) 2007-10-30
DE69231063T2 (de) 2001-01-11
US6126935A (en) 2000-10-03

Similar Documents

Publication Publication Date Title
DK0970701T3 (da) Pellets afledt fra keratinocytter til anvendelse som sårhelingsstoffer
DK0451611T3 (da) Human hæmatopoietisk stamcelle
ATE447009T1 (de) Verfahren zur herstellung angereicherter hämatopoietischer zusammensetzungen, dadurch hergestellte zusammensetzungen sowie deren verwendungen
EA200601231A1 (ru) Дефинитивная энтодерма
DK109989D0 (da) Regenerering af gramini-planter af underfamilien pooideae ud fra protoplaster
DK0389063T3 (da) Fremgangsmåde til isolering af nukleinsyre
DK0891420T4 (da) Fremgangsmåde til replikation af influenzavirus i cellekultur samt de ved fremgangsmåden opnåelige influenzavirus
ES2121803T3 (es) Plantas de zea mays y plantas transgenicas de zea mays generadas a partir de protoplastos o celulas derivadas de protoplastos.
ATE352613T1 (de) Chimäres tier und methode zu dessen herstellung
ATE92530T1 (de) Transformation und expression eines fremden gens in -i(brassica) spezies.
ATE361056T1 (de) Lippenbehandlungsmittel enthaltend ein derivat von hefezellen
NO972171L (no) Regulering av neural stamcelleproliferasjon
SI1428878T1 (sl) Postopek za proizvodnjo in čiščenje eritropoietina
DE59309926D1 (de) Modul zur Züchtung und zur Nutzung der Stoffwechselleistung und/oder zum Erhalt von Mikroorganismen
WO2004090096A3 (en) Methods for neural differentiation of embryonic stem cells using protease passaging techniques
ES2055611T3 (es) Pdgf resistente a proteasas y metodos de uso.
ATE330003T1 (de) Rekombinanter stabiler zellklon, seine herstellung und verwendung
DK1235901T3 (da) Fremgangsmåde til fremstilling af celletransplantater
PL367306A1 (pl) Szczepionki na bazie autologicznych komórek T i sposoby ich otrzymywania
ATE29213T1 (de) Mikrobielles haartonikum.
DE3666458D1 (en) Method and device for the _i(in vitro) culture of plant cells and organs, as well as for the micropropagation and regeneration of complete plants
FR2855183B1 (fr) Procede de clonage du rat par transfert nucleaire
DK1238057T3 (da) Fremgangsmåde til produktion af vedhæftende dyreceller
DK0485504T3 (da) Fremgangsmåde til fremstilling af aktiveret protein C ved celledyrkning
ATE9226T1 (de) Methyl-4-oxatricyclo(5.2.1.02,6)-dec-8-en-3-on (i) und methyl-4-oxatricyclo(5.2.1.02,6)-decan-3- on (ii), deren herstellung und deren verwendung als riechstoffe.